782 related articles for article (PubMed ID: 20159883)
21. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
22. Effect of Preconception Impaired Glucose Tolerance on Pregnancy Outcomes in Women With Polycystic Ovary Syndrome.
Wei D; Zhang B; Shi Y; Zhang L; Zhao S; Du Y; Xu L; Legro RS; Zhang H; Chen ZJ
J Clin Endocrinol Metab; 2017 Oct; 102(10):3822-3829. PubMed ID: 28938429
[TBL] [Abstract][Full Text] [Related]
23. Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review.
Anwar S; Shikalgar N
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S913-S917. PubMed ID: 28711517
[TBL] [Abstract][Full Text] [Related]
24. Impaired glucose metabolism in women with polycystic ovary syndrome.
Vrbikova J; Fanta M; Cibula D; Vondra K; Bendlova B
Gynecol Obstet Invest; 2009; 68(3):186-90. PubMed ID: 19672087
[TBL] [Abstract][Full Text] [Related]
25. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.
Norman RJ; Masters L; Milner CR; Wang JX; Davies MJ
Hum Reprod; 2001 Sep; 16(9):1995-8. PubMed ID: 11527911
[TBL] [Abstract][Full Text] [Related]
26. Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.
Salley KE; Wickham EP; Cheang KI; Essah PA; Karjane NW; Nestler JE
J Clin Endocrinol Metab; 2007 Dec; 92(12):4546-56. PubMed ID: 18056778
[TBL] [Abstract][Full Text] [Related]
27. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
28. Medical conditions associated with recurrent miscarriage-Is BMI the tip of the iceberg?
Matjila MJ; Hoffman A; van der Spuy ZM
Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():91-96. PubMed ID: 28494269
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic biomarkers of impaired glucose tolerance and type 2 diabetes mellitus with a potential for risk stratification in women with polycystic ovary syndrome.
Galazis N; Iacovou C; Haoula Z; Atiomo W
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):121-30. PubMed ID: 22136882
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome.
Espinós-Gómez JJ; Corcoy R; Calaf J
Gynecol Endocrinol; 2009 Mar; 25(3):199-204. PubMed ID: 19347711
[TBL] [Abstract][Full Text] [Related]
31. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
[TBL] [Abstract][Full Text] [Related]
32. Visceral adiposity index and DHEAS are useful markers of diabetes risk in women with polycystic ovary syndrome.
Amato MC; Magistro A; Gambino G; Vesco R; Giordano C
Eur J Endocrinol; 2015 Jan; 172(1):79-88. PubMed ID: 25342852
[TBL] [Abstract][Full Text] [Related]
33. The association between obstructive sleep apnea and metabolic abnormalities in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Kahal H; Kyrou I; Uthman O; Brown A; Johnson S; Wall P; Metcalfe A; Tahrani AA; Randeva HS
Sleep; 2018 Jul; 41(7):. PubMed ID: 29722890
[TBL] [Abstract][Full Text] [Related]
34. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
35. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome.
Chen X; Yang D; Li L; Feng S; Wang L
Hum Reprod; 2006 Aug; 21(8):2027-32. PubMed ID: 16684838
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive evaluation of disparities in cardiometabolic and reproductive risk between Hispanic and White women with polycystic ovary syndrome in the United States: a systematic review and meta-analysis.
Kazemi M; Kim JY; Wan C; Xiong JD; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2022 Feb; 226(2):187-204.e15. PubMed ID: 34384776
[TBL] [Abstract][Full Text] [Related]
37. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome.
Palmert MR; Gordon CM; Kartashov AI; Legro RS; Emans SJ; Dunaif A
J Clin Endocrinol Metab; 2002 Mar; 87(3):1017-23. PubMed ID: 11889155
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome.
Trakakis E; Basios G; Peppa M; Simeonidis G; Labos G; Creatsa M; Misailidou M; Boutati E; Vaggopoulos V; Panagopoulos P; Dimitriades G; Kassanos D
Gynecol Endocrinol; 2012 Nov; 28(11):867-70. PubMed ID: 22571176
[TBL] [Abstract][Full Text] [Related]
39. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
Wehr E; Gruber HJ; Giuliani A; Möller R; Pieber TR; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2011 Jun; 96(6):E986-90. PubMed ID: 21470992
[TBL] [Abstract][Full Text] [Related]
40. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
Joham AE; Boyle JA; Zoungas S; Teede HJ
Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
